InvestorsHub Logo
Followers 17
Posts 936
Boards Moderated 0
Alias Born 04/26/2010

Re: Suvorov post# 215520

Friday, 02/02/2018 11:26:43 AM

Friday, February 02, 2018 11:26:43 AM

Post# of 403134
I don't contest your example of the abuse of preferred shares. Surely true. But you seem to be saying that the same is an imminent risk with IPIX. I beg to differ. IPIX has some less dilutive means of financing left like Aspire 30 M common class A share purchase agreement:

Assuming that IPIX's short term activity stays at year 2017 level (around 15 M a year) IPIX has about 2 years left before desperation times come. I have assumed for solvent time: IPIX does not wind down (as they seem to be doing) their trial activities for the duration of partnership negotiations and the end of all partnership negotiations will be no deal whatsoever. Then, if IPIX is still without a partnership or funds from a patent sale, might be time to worry about preferred stocks.

Considering current convertible loan situation this can be found the latest 10-K by IPIX:

4,078,232 shares of Class A common stock into which a convertible loan in the amount of $2,022,264 and accrued interest $16,852 may be converted at $0.50 per share



Those shares are included in the reported total of 34,165,544 shares owned by Leo Ehrlich. So, as of now, no loans convertible to preferred stock, not even to class B stocks. And, unless changes are made or there exist un-reported and denied off the books loan arrangements no additional insider loans to convert into anything.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News